INSIGHTS ON CLINICAL TRIAL DESIGN

• Data Key In Addressing Patient Recruitment Challenges

  Explore how a Phase II trial for extensive-stage and previously treated small cell lung cancer overcame recruitment challenges with a data-driven solution designed to surface protocol-matched patients.

• Why Clinical Trial Demographics Don't Match Real-World Populations

  Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.

• Why We Need To Look To The Future Of Clinical Trials

  Explore how decentralized trial elements, community-focused site networks, and patient-centric infrastructure can improve recruitment, data quality, equity, and efficiency.

• Critical Imaging Risks In GLP-1 And Neurology Studies

  As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that supports participant safety and reproducible outcomes.

• How To Streamline The Complexity Of Clinical Trials

  1/30/2026

  Streamlining intricate end-to-end processes ensures that data moves with speed and security, converting the current landscape of logistical bottlenecks into a transparent, high-efficiency engine.

• Addressing Trial Design Hurdles Across Alzheimer's Disease Stages

  12/10/2025

  Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.

• Rapid Expansion Of Peptide And Nanobody Drug Conjugates

  7/21/2026

  Peptide and nanobody drug conjugates are gaining momentum, with 106 active programs identified globally. Learn more about the fast-evolving space for targeted drug delivery and competitive opportunities.

• Investigator SmartSelect

  10/23/2024

  This advanced recommendation engine identifies protocol-specific investigators in just minutes, dramatically shortening a process that typically takes four to six weeks.

• Digital Transformation As A Foundation For Modern Chronic Disease Trials

  6/16/2026

  Site-centric chronic trials cause patient burden. Learn how wearables and a decentralized model can shift research to continuous data capture, removing travel barriers to improve retention and disease tracking.